Sign In
Buy OTCM
$51.80
-0.200 (-0.385%)
At Close: Jun 03, 2026
OTC Markets Group Reports Fourth Quarter and Full Year 2024 Results Delivering Revenue Growth
05:15pm, Wednesday, 12'th Mar 2025
Fourth Quarter and Full Year 2024 Highlights: Gross revenues of $111.1 million for the year, up 1% versus 2023 Operating income of $32.2 million for the year, down 1% versus 2023 Operating profit marg
OTC Markets Group Welcomes Kootenay Silver, Inc. to OTCQX
07:00am, Wednesday, 12'th Mar 2025
NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Kootenay Silver,
OTC Markets Group Welcomes 1895 Bancorp of Wisconsin, Inc.to OTCQX
07:00am, Monday, 10'th Mar 2025
NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced 1895 Bancorp of W
OTC Markets Group Announces Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast
04:00pm, Wednesday, 05'th Mar 2025
NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM) today announced it will report its financial results for the fourth quarter and fiscal year ended December 31, 2024, a
OTC Markets Group: The Moat-Rich, Undervalued Trading System Operator Under Our Noses
08:39am, Friday, 28'th Feb 2025
OTC Markets Group operates alternative trading systems with a strong competitive moat: legally enforced monopoly, customer dependency, operating leverage, which (thanks to their subscription models) i
OTC Markets Group Welcomes White Pearl Technology Group AB to OTCQX
07:00am, Friday, 28'th Feb 2025
NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced White Pearl Techno
OTC Markets Group Welcomes Perimeter Medical Imaging AI, Inc. to OTCQX
07:00am, Thursday, 27'th Feb 2025
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Perimeter Medical
OTC Markets Group Welcomes Li-Cycle Holdings Corp. to OTCQX
07:00am, Thursday, 27'th Feb 2025
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced that Li-Cycle Hold
OTC Markets expands overnight trading infrastructure with DriveWealth
01:10pm, Monday, 24'th Feb 2025
Financial technology platform DriveWealth has partnered with OTC Markets Group Inc. (OTCQX:OTCM) to expand its overnight trading capabilities. Set to launch in March, the collaboration will allow Driv
OTC Markets Group Welcomes ZRCN Inc. to OTCQX for Trading
10:52am, Monday, 24'th Feb 2025
NEW YORK , Feb. 24, 2025 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced ZRCN Inc. (OTCQX:
OTC Markets Group Welcomes ZRCN Inc. to OTCQX
07:00am, Monday, 24'th Feb 2025
NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced ZRCN Inc. (OTCQX:
Thiogenesis Announces European Consulting and Investor Relations Agreement
09:00am, Thursday, 20'th Feb 2025
San Diego, California--(Newsfile Corp. - February 20, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company") a clinical-stage biotechnology company develop
OTC Markets Group Welcomes Concurrent Technologies Plc to OTCQX
07:00am, Thursday, 13'th Feb 2025
NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Concurrent Technol
Thiogenesis Announces Commencement of OTCQX Trading in the U.S.
09:00am, Wednesday, 12'th Feb 2025
San Diego, California--(Newsfile Corp. - February 12, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company") a clinical-stage biotechnology company develop
OTC Markets Group Welcomes Thiogenesis Therapeutics, Corp. to OTCQX
07:00am, Wednesday, 12'th Feb 2025
NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Thiogenesis Therap
